MX2019013377A - Procedimiento de detección de enfermedades inducidas por c. perfringens en animales. - Google Patents

Procedimiento de detección de enfermedades inducidas por c. perfringens en animales.

Info

Publication number
MX2019013377A
MX2019013377A MX2019013377A MX2019013377A MX2019013377A MX 2019013377 A MX2019013377 A MX 2019013377A MX 2019013377 A MX2019013377 A MX 2019013377A MX 2019013377 A MX2019013377 A MX 2019013377A MX 2019013377 A MX2019013377 A MX 2019013377A
Authority
MX
Mexico
Prior art keywords
marker
perfringens
animals
sample material
specific
Prior art date
Application number
MX2019013377A
Other languages
English (en)
Inventor
Stefan Pelzer
Richard Ducatelle
Frank Thiemann
Monika Flügel
Immerseel Filip Van
Evy Goossens
Florian Böhl
Sarah Hark
Original Assignee
Evonik Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Operations Gmbh filed Critical Evonik Operations Gmbh
Priority claimed from PCT/EP2018/062090 external-priority patent/WO2018206690A1/en
Publication of MX2019013377A publication Critical patent/MX2019013377A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un procedimiento de detección de enfermedades inducidas por C. perfringens en animales, comprendiendo el procedimiento: a) recoger el material de muestra de un animal específico o de un grupo específico de animales en momentos consecutivos; b) determinar la cantidad de un primer marcador y un segundo marcador contenidos en el material de muestra; y c) determinar la proporción del primer marcador con respecto al segundo marcador contenidos en el material de muestra; en el que el primer marcador comprende una secuencia de polinucleótidos que es específica para la subespecie de C. perfringens que induce la enfermedad diana; y el segundo marcador comprende un polinucleótido que es específico para la especie C. perfringens; y en el que un aumento en la proporción del primer marcador con respecto al segundo marcador en el material de muestra analizado a lo largo del tiempo es una indicación de la enfermedad diana.
MX2019013377A 2017-05-12 2018-05-09 Procedimiento de detección de enfermedades inducidas por c. perfringens en animales. MX2019013377A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP17170811 2017-05-12
US201762531000P 2017-07-11 2017-07-11
CN201710646838 2017-08-01
PCT/EP2018/062090 WO2018206690A1 (en) 2017-05-12 2018-05-09 Method for detecting c. perfringens induced diseases in animals

Publications (1)

Publication Number Publication Date
MX2019013377A true MX2019013377A (es) 2020-09-21

Family

ID=62116895

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019013377A MX2019013377A (es) 2017-05-12 2018-05-09 Procedimiento de detección de enfermedades inducidas por c. perfringens en animales.

Country Status (14)

Country Link
US (1) US11643696B2 (es)
EP (2) EP3636774B1 (es)
KR (1) KR20200006108A (es)
CN (1) CN110832089A (es)
BR (1) BR112019023772A2 (es)
CA (1) CA3063287A1 (es)
DK (2) DK3636774T3 (es)
ES (2) ES2944359T3 (es)
HU (2) HUE055897T2 (es)
MX (1) MX2019013377A (es)
MY (1) MY201961A (es)
PL (2) PL3636774T3 (es)
RU (2) RU2769503C2 (es)
ZA (1) ZA201908057B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210011027A1 (en) 2018-03-02 2021-01-14 Evonik Operations Gmbh In vitro method for detecting intestinal barrier failure in animals by determining ovotransferrin
CN112166198A (zh) * 2018-05-29 2021-01-01 赢创运营有限公司 监测动物种群中病原体负荷的体外方法
BR112020025403A2 (pt) * 2018-06-15 2021-03-16 Evonik Operations Gmbh Método para a detecção precoce de um surto de enterite necrótica em uma população aviária e uso do método
MX2021006917A (es) 2018-12-14 2021-07-07 Evonik Operations Gmbh Procedimiento in vitro para la deteccion de disbiosis intestinal aviar.
CN116121418A (zh) * 2022-12-30 2023-05-16 福建傲芯种业科技集团有限公司 一种猪魏氏梭菌鉴别分型的荧光探针引物、试剂盒及其应用
US20260009093A1 (en) * 2024-07-05 2026-01-08 Daro, Llc Animal pathogen surveillance system

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538851A (en) * 1993-12-22 1996-07-23 Institut Pasteur And Cneva Primers for the amplification of genes coding for the enterotoxin and the lecithinase of Clostridium perfringens and their application to the determination of the presence and numeration of these bacteriae
US6218529B1 (en) * 1995-07-31 2001-04-17 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
FR2788780B1 (fr) 1999-01-27 2001-03-30 Ap Cells Inc Procede de preparation de vesicules membranaires
GB9927320D0 (en) 1999-11-18 2000-01-12 Chiron Spa Exosome separation
US6812023B1 (en) 2000-04-27 2004-11-02 Anosys, Inc. Methods of producing membrane vesicles
US20040101860A1 (en) 2002-11-27 2004-05-27 Jones Alison M. Predicting animal performance
WO2005019258A2 (en) 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US7374927B2 (en) * 2004-05-03 2008-05-20 Affymetrix, Inc. Methods of analysis of degraded nucleic acid samples
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
US8058000B2 (en) 2005-06-02 2011-11-15 The United States Of America As Represented By The U.S. Environmental Protection Agency Species-specific primer sets and identification of species-specific DNA sequences using genome fragment enrichment
US20070042354A1 (en) 2005-08-19 2007-02-22 Engelhard Eric K Detecting pathogens in companion animals
KR100920971B1 (ko) 2007-03-08 2009-10-09 삼성에버랜드 주식회사 식품 위해 미생물 검출용 프라이머 및 이를 이용한 식품위해 미생물 검출방법
BRPI0812346B1 (pt) * 2007-06-08 2019-01-22 Australian Poultry Crc Pty Ltd célula hospedeira, método para a produção de um polipeptídeo isolado, composição, vacinas, método de atenuação da virulência de uma bactéria, método para determinar se um indivíduo foi exposto a um patógeno e uso da célula hospedeira, das vacinas ou da bactéria
CA2743211A1 (en) 2008-11-12 2010-05-20 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Methods and systems of using exosomes for determining phenotypes
US20160041153A1 (en) 2008-11-12 2016-02-11 Kirk Brown Biomarker compositions and markers
IT1406051B1 (it) 2010-08-05 2014-02-06 D M G Italia S R L Uso di hmgb1 come marcatore biologico di infiammazione intestinale umana, metodo non invasivo per la sua rilevazione in campioni fecali e kit relativo.
EP2495025A1 (en) 2011-03-04 2012-09-05 Fresenius Medical Care Deutschland GmbH Filter for the removal of micro-vesicles from biological fluids, methods and devices using such a filter
WO2012149438A1 (en) 2011-04-28 2012-11-01 Life Technologies Corporation Methods and compositions for multiplex pcr
RU2472162C1 (ru) 2011-05-04 2013-01-10 Государственное научное учреждение Всероссийский научно-исследовательский институт экспериментальной ветеринарии им. Я.Р. Коваленко Россельхозакадемии Способ серологической диагностики вирусных желудочно-кишечных инфекций крупного рогатого скота методом иммуноферментного анализа
CN102697812B (zh) 2012-05-28 2013-08-14 山东农业大学 鸡胆汁来源的胞外体提取方法及其在免疫学上的应用
EP2875348B1 (en) 2012-07-19 2018-09-26 Atlantic Cancer Research Institute Method for the isolation of microvesicles
JP2015532302A (ja) * 2012-10-02 2015-11-09 オイル−ドリ・コーポレイション・オブ・アメリカ クレイ製品およびその使用
KR101922128B1 (ko) 2012-12-04 2019-02-13 삼성전자주식회사 미세유동장치 및 이를 채용한 생물학적 시료 내의 표적 물질 농축방법
EP2746406B1 (en) 2012-12-18 2017-08-23 Samsung Electronics Co., Ltd. Composition and kit for diagnosing breast cancer including miRNAs within vesicle, and method of diagnosing breast cancer using the same
US20150353920A1 (en) 2013-01-03 2015-12-10 Exosome Diagnostics, Inc. Methods for isolating microvesicles
JP2015039320A (ja) 2013-08-21 2015-03-02 日鉄住金環境株式会社 複数細菌の同時検出及び／又は定量方法
WO2015103710A1 (en) * 2014-01-13 2015-07-16 The Royal Institution For The Advancement Of Learning/Mcgill University Methods, reagents and kits for the assessment of bacterial infection
CA2955300A1 (en) 2014-07-16 2016-01-21 General Mills, Inc. Bulk allele discrimination assay
CN104531867B (zh) 2014-12-25 2017-03-29 湖北省农业科学院畜牧兽医研究所 产气荚膜梭菌肠毒素阳性菌双重荧光定量pcr快速检测试剂盒
EP3112474A1 (en) 2015-06-29 2017-01-04 Evonik Degussa GmbH Method of detecting avian necrotic enteritis
CN104807992A (zh) * 2015-04-25 2015-07-29 东北农业大学 一种检测产气荚膜梭菌NetB毒素抗体的阻断ELISA方法
WO2016201272A1 (en) * 2015-06-12 2016-12-15 King Abdulaziz City For Science And Technology Method of diagnosing patients with conditions caused by mendelian mutations
CN107090518B (zh) 2017-04-05 2020-03-20 苏州协云基因科技有限公司 腹泻相关病原体多重rt-pcr联合基因芯片检测试剂盒
CN111164225A (zh) 2017-10-02 2020-05-15 赢创运营有限公司 用于指导对抗动物群中沙门氏菌的繁殖和/或弯曲杆菌的繁殖的措施的过程中方法
US20210011027A1 (en) 2018-03-02 2021-01-14 Evonik Operations Gmbh In vitro method for detecting intestinal barrier failure in animals by determining ovotransferrin
CN112166198A (zh) 2018-05-29 2021-01-01 赢创运营有限公司 监测动物种群中病原体负荷的体外方法
BR112020025403A2 (pt) * 2018-06-15 2021-03-16 Evonik Operations Gmbh Método para a detecção precoce de um surto de enterite necrótica em uma população aviária e uso do método

Also Published As

Publication number Publication date
US11643696B2 (en) 2023-05-09
ES2893470T3 (es) 2022-02-09
RU2019139169A3 (es) 2021-09-13
RU2021135658A (ru) 2021-12-16
US20220025439A9 (en) 2022-01-27
PL3636774T3 (pl) 2022-01-03
DK3622082T3 (da) 2023-06-12
EP3636774A1 (en) 2020-04-15
US20210139955A1 (en) 2021-05-13
RU2769503C2 (ru) 2022-04-01
CA3063287A1 (en) 2018-11-15
RU2019139169A (ru) 2021-06-15
EP3636774B1 (en) 2021-08-25
DK3636774T3 (da) 2021-11-15
PL3622082T3 (pl) 2023-07-31
HUE055897T2 (hu) 2021-12-28
KR20200006108A (ko) 2020-01-17
ZA201908057B (en) 2024-07-31
BR112019023772A2 (pt) 2020-06-09
MY201961A (en) 2024-03-27
CN110832089A (zh) 2020-02-21
EP3622082A1 (en) 2020-03-18
EP3622082B1 (en) 2023-03-29
ES2944359T3 (es) 2023-06-20
HUE062498T2 (hu) 2023-11-28

Similar Documents

Publication Publication Date Title
ZA201908057B (en) Method for detecting c. perfringens induced diseases in animals
IL283845A (en) Methods for detecting disease using analysis of rna
EP3948772A4 (en) METHODS AND SYSTEM FOR SELECTING EMBRYONS
EP3891755A4 (en) IDENTIFICATION, EXTRACTION AND PREDICTION SYSTEM FOR CLINICAL CONCEPTS AND RELATED PROCEDURES
EA201892489A1 (ru) Число мишеней для мультиплексной оптимизированной амплификации с несоответствиями (moma)
SG10201903822XA (en) Method for the enrichment of circulating tumor dna
PH12017501967A1 (en) Maize plant dbn9936 and method for use in detecting nucleic acid sequence thereof
PH12015502849A1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
MX2014004794A (es) Seleccion de protocolo preferido de manejo y procesamiento de muestras para identificacion de biomarcadores de enfermedad y valoracion de calidad de muestra.
EP3705052C0 (en) BIOLOGICAL SAMPLE COLLECTION DEVICE
WO2017079653A3 (en) Methods of detecting inflammatory markers and treating inflammatory conditions in companion animals
EP3765478A4 (en) METHODS FOR QUANTIFICATION OF RNA AND DNA VARIANTS BY SEQUENCING USING PHOSPHOROTHIOATES
SG10201806729VA (en) Novel assay to detect human periostin
MX2020009045A (es) Procedimiento in vitro para detectar disfuncion de la barrera intestinal en animales mediante la determinacion de ovotransferrina.
EP3779418A4 (en) APPARATUS FOR QUANTITATIVE ANALYSIS IN AMORPHIC PHASE, PROCESS FOR QUANTITATIVE ANALYSIS IN AMORPHIC PHASE AND PROGRAM FOR QUANTITATIVE ANALYSIS IN AMORPHIC PHASE
EP3859338A4 (en) HEMOGLOBIN TEST REAGENT, TEST KIT AND TEST PROCEDURE
EA201391408A1 (ru) Способ прогнозирования стиля передвижения у лошадей
MX384485B (es) Deteccion temprana de preeclampsia.
EP3965656A4 (en) Implantable apparatus for sensing biologic signals
FR3066071B1 (fr) Dispositif pour la collecte et la restitution de molecules odorantes et methode de detection.
EP3928713A4 (en) EVALUATION DEVICE, EVALUATION METHOD AND EVALUATION PROGRAM
EP3906406C0 (en) DEVICE AND METHOD FOR MEASURING THE WATER CONTENT OF SOIL, VEGETATION AND SNOW
RU2020112659A (ru) ВНУТРИПРОИЗВОДСТВЕННЫЙ СПОСОБ ОБЕСПЕЧЕНИЯ МЕР, НАПРАВЛЕННЫХ ПРОТИВ РАЗМНОЖЕНИЯ Salmonella И/ИЛИ ПРОТИВ РАЗМНОЖЕНИЯ Campylobacter В ПОГОЛОВЬЕ ЖИВОТНЫХ
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
BR112017017182A2 (pt) composto para tratamento de doenças ou condições por inibição da atividade ou expressão de gh, ghr, stat5, igf-1 e/ou socs e de proteínas reguladas por gh, ghr, stat5, socs, igf-1 e insulina humanos; compostos para tratamento de doenças ou condições por inibição da atividade ou expressão de gh, ghr, stat5, socs, igf-1 e insulina e de proteínas reguladas por gh, ghr, stat5, socs, igf-1 e insulina humanos; método para tratamento de doenças ou condições com alterações em genes da sinalização relacionados com gh, ghr, stat5 e socs humanos; e método para tratamento de doenças ou condições causadas por atividade de hormônios do crescimento